Turo J Nurmikko

Summary

Affiliation: University of Liverpool
Country: UK

Publications

  1. ncbi request reprint Mechanisms of central pain
    T J Nurmikko
    Pain Research Institute, University Department of Neurological Science, The Walton Centre for Neurology and Neurosurgery NHS Trust, Liverpool, England
    Clin J Pain 16:S21-5. 2000
  2. ncbi request reprint Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis
    David J Rog
    Walton Centre for Neurology and Neurosurgery, University of Liverpool, Liverpool, United Kingdom
    Neurology 65:812-9. 2005
  3. ncbi request reprint Sativex successfully treats neuropathic pain characterised by allodynia: a randomised, double-blind, placebo-controlled clinical trial
    Turo J Nurmikko
    Division of Neurological Science, University of Liverpool, Liverpool, United Kingdom
    Pain 133:210-20. 2007
  4. ncbi request reprint Oromucosal delta9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: an uncontrolled, open-label, 2-year extension trial
    David J Rog
    Walton Centre for Neurology and Neurosurgery, Liverpool, United Kingdom
    Clin Ther 29:2068-79. 2007
  5. doi request reprint Ipsilateral cortical activation in fibromyalgia patients during brushing correlates with symptom severity
    Nicholas Fallon
    Department of Experimental Psychology, Institute of Psychology, Health, and Society, University of Liverpool, Liverpool, United Kingdom
    Clin Neurophysiol 124:154-63. 2013
  6. doi request reprint Development and preliminary validation of the NePIQoL: a quality-of-life measure for neuropathic pain
    Helen M Poole
    School of Psychology, Faculty of Science, Liverpool John Moores University, Liverpool, United Kingdom
    J Pain Symptom Manage 37:233-45. 2009
  7. pmc Cortical activation changes during repeated laser stimulation: a magnetoencephalographic study
    Andrej Stancak
    Department of Experimental Psychology, Institute of Psychology, Health, and Society, University of Liverpool, Liverpool, United Kingdom
    PLoS ONE 6:e19744. 2011
  8. ncbi request reprint Validation and reliability of the Neuropathic Pain Scale (NPS) in multiple sclerosis
    David J Rog
    Walton Centre for Neurology and Neurosurgery, Liverpool, UK
    Clin J Pain 23:473-81. 2007
  9. ncbi request reprint Recommendations for the management of herpes zoster
    Robert H Dworkin
    Department of Anesthesiology, University of Rochester School of Medicine and Dentistry, Rochester, NY, 14642, USA
    Clin Infect Dis 44:S1-26. 2007
  10. pmc Analgesic therapy in postherpetic neuralgia: a quantitative systematic review
    Kathleen Hempenstall
    Royal Hampshire County Hospital, Winchester, United Kingdom
    PLoS Med 2:e164. 2005

Detail Information

Publications11

  1. ncbi request reprint Mechanisms of central pain
    T J Nurmikko
    Pain Research Institute, University Department of Neurological Science, The Walton Centre for Neurology and Neurosurgery NHS Trust, Liverpool, England
    Clin J Pain 16:S21-5. 2000
    ..All models inherently assume a degree of specialization of cerebral structures in pain processing, which has not been proved conclusively...
  2. ncbi request reprint Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis
    David J Rog
    Walton Centre for Neurology and Neurosurgery, University of Liverpool, Liverpool, United Kingdom
    Neurology 65:812-9. 2005
    ..Central pain in multiple sclerosis (MS) is common and often refractory to treatment...
  3. ncbi request reprint Sativex successfully treats neuropathic pain characterised by allodynia: a randomised, double-blind, placebo-controlled clinical trial
    Turo J Nurmikko
    Division of Neurological Science, University of Liverpool, Liverpool, United Kingdom
    Pain 133:210-20. 2007
    ..Of all participants, 18% on sativex and 3% on placebo withdrew during the study. An open-label extension study showed that the initial pain relief was maintained without dose escalation or toxicity for 52 weeks...
  4. ncbi request reprint Oromucosal delta9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: an uncontrolled, open-label, 2-year extension trial
    David J Rog
    Walton Centre for Neurology and Neurosurgery, Liverpool, United Kingdom
    Clin Ther 29:2068-79. 2007
    ..Delta(9)-Tetrahydrocannabinol/cannabidiol (THC/CBD), an endocannabinoid system modulator, has demonstrated efficacy for up to 4 weeks in randomized controlled trials in the treatment of CNP in patients with MS...
  5. doi request reprint Ipsilateral cortical activation in fibromyalgia patients during brushing correlates with symptom severity
    Nicholas Fallon
    Department of Experimental Psychology, Institute of Psychology, Health, and Society, University of Liverpool, Liverpool, United Kingdom
    Clin Neurophysiol 124:154-63. 2013
    ..To evaluate cortical activation patterns during mechanical-tactile stimulation in fibromyalgia syndrome (FMS) patients and to correlate cortical activation changes with clinical symptoms...
  6. doi request reprint Development and preliminary validation of the NePIQoL: a quality-of-life measure for neuropathic pain
    Helen M Poole
    School of Psychology, Faculty of Science, Liverpool John Moores University, Liverpool, United Kingdom
    J Pain Symptom Manage 37:233-45. 2009
    ..The authors conclude that the NePIQoL is an acceptable, patient-derived, neuropathic pain-specific measure with evidence of reliability, validity, and temporal stability...
  7. pmc Cortical activation changes during repeated laser stimulation: a magnetoencephalographic study
    Andrej Stancak
    Department of Experimental Psychology, Institute of Psychology, Health, and Society, University of Liverpool, Liverpool, United Kingdom
    PLoS ONE 6:e19744. 2011
    ..Results point to a pivotal role of the contralateral operculo-insular region in processing of C-fibre mediated pain during repeated subnoxious laser stimulation...
  8. ncbi request reprint Validation and reliability of the Neuropathic Pain Scale (NPS) in multiple sclerosis
    David J Rog
    Walton Centre for Neurology and Neurosurgery, Liverpool, UK
    Clin J Pain 23:473-81. 2007
    ..The Neuropathic Pain Scale (NPS) has received preliminary validation in peripheral neuropathic pain conditions. The aim of this study was to validate its use in MS central pain syndromes...
  9. ncbi request reprint Recommendations for the management of herpes zoster
    Robert H Dworkin
    Department of Anesthesiology, University of Rochester School of Medicine and Dentistry, Rochester, NY, 14642, USA
    Clin Infect Dis 44:S1-26. 2007
    ..Specific recommendations for the use of these medications are provided. In addition, suggestions are made for treatments that, when used in combination with antiviral therapy, may further reduce pain and other complications of HZ...
  10. pmc Analgesic therapy in postherpetic neuralgia: a quantitative systematic review
    Kathleen Hempenstall
    Royal Hampshire County Hospital, Winchester, United Kingdom
    PLoS Med 2:e164. 2005
    ..Therefore, we have conducted a systematic review and meta-analysis for both efficacy and adverse events of analgesic therapy for PHN...
  11. ncbi request reprint Pharmacologic management of neuropathic pain: evidence-based recommendations
    Robert H Dworkin
    University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA
    Pain 132:237-51. 2007
    ..Long-term studies, head-to-head comparisons between medications, studies involving combinations of medications, and RCTs examining treatment of central NP are lacking and should be a priority for future research...